Skip to main content
Unit of study_

PHAR4811: Pharmacotherapeutics

2024 unit information

This unit of study will focus on developing students' understanding of the use of medicines and related appropriate health measures in special patient populations (paediatrics, geriatrics, pregnancy, disability and Special Patient Groups). The unit of study will draw upon concepts in clinical pharmacy, pharmacokinetics and clinical practice. Through a series of workshops, students will undertake activities including case-study analysis, role-plays, problem solving and case presentations. These activities will help students explore information sources for drug use and integrate knowledge of clinical indices, laboratory data, medication use history and demographic information to optimise drug therapy in response to the needs of individual patients. Students will gain 'hands-on' practice in the provision of patient-specific medicine use education and explore key issues concerning the maintenance of vigilance for medicines use specific to certain population groups.

Unit details and rules

Managing faculty or University school:

Pharmacy

Code PHAR4811
Academic unit Pharmacy
Credit points 6
Prerequisites:
? 
PHAR3100 and PHAR3815 and PHAR3825 and PHAR3816 and PHAR3817 and PHAR3818 and PHAR3819 and PHAR3826 and PHAR3827 and PHAR3820
Corequisites:
? 
PHAR4812 and (PHAR4814 or PHAR4815 or WORK3202 or WORK2222) and PHAR4823 and PHAR4100
Prohibitions:
? 
None
Assumed knowledge:
? 
None

At the completion of this unit, you should be able to:

  • LO1. demonstrate an understanding of particular therapeutic issues in paediatric, geriatric, palliative care and other special patient populations such as pregnant and lactating women, people living with disability, LGBTQIA+ community
  • LO2. apply knowledge of pharmacology, immunology, microbiology, medicinal chemistry, and therapeutics in recommending appropriate drug therapy in special patient populations
  • LO3. develop appropriate dosing regimens based on patient characteristics in special cases such as paediatric, geriatric, palliative, and pregnant and lactating patients
  • LO4. select the appropriate drug (device) in the correct dose, recommend appropriate delivery systems and use biopharmaceutics and pharmacokinetic data in specialised situations (paediatric, geriatric, pregnant, excipient intolerance/allergies and diverse health/religious beliefs)
  • LO5. access, analyse and interpret professional, lay and scientific literature to provide drug information to patients, families, carers and other health care providers involved in special patient cases
  • LO6. learn independently and engage in continuous reflection and take responsibility for personal and professional development
  • LO7. demonstrate capacity and skills in developing and completing group tasks in a timely manner
  • LO8. demonstrate competence in the delivery of clinical presentations to peers

Unit availability

This section lists the session, attendance modes and locations the unit is available in. There is a unit outline for each of the unit availabilities, which gives you information about the unit including assessment details and a schedule of weekly activities.

The outline is published 2 weeks before the first day of teaching. You can look at previous outlines for a guide to the details of a unit.

Session MoA ?  Location Outline ? 
Semester 1 2024
Normal day Camperdown/Darlington, Sydney
Session MoA ?  Location Outline ? 
Semester 1 2020
Normal day Camperdown/Darlington, Sydney
Semester 1 2021
Normal day Remote
Semester 1 2022
Normal day Camperdown/Darlington, Sydney
Semester 1 2023
Normal day Camperdown/Darlington, Sydney

Modes of attendance (MoA)

This refers to the Mode of attendance (MoA) for the unit as it appears when you’re selecting your units in Sydney Student. Find more information about modes of attendance on our website.